Healthcare provider profile · identity verified

Todd Kenneth Rosenthal, MD

Internal Medicine · TAMPA, FL · NPI 1760403307

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Alprazolam	Alprazolam	426	77
Atorvastatin Calcium	Atorvastatin Calcium	383	142
Lisinopril	Lisinopril	281	94
Amlodipine Besylate	Amlodipine Besylate	264	95
Tramadol Hcl	Tramadol Hcl	233	64
Levothyroxine Sodium	Levothyroxine Sodium	217	72
Losartan Potassium	Losartan Potassium	207	79
Albuterol Sulfate Hfa	Albuterol Sulfate	177	58
Pantoprazole Sodium	Pantoprazole Sodium	162	55
Metformin Hcl	Metformin Hcl	157	59
Simvastatin	Simvastatin	155	53
Omeprazole	Omeprazole	145	56
Metoprolol Tartrate	Metoprolol Tartrate	130	46
Tamsulosin Hcl	Tamsulosin Hcl	130	48
Tizanidine Hcl	Tizanidine Hcl	128	51
Rosuvastatin Calcium	Rosuvastatin Calcium	124	52
Gabapentin	Gabapentin	117	40
Carvedilol	Carvedilol	104	39
Furosemide	Furosemide	91	34
Hydrochlorothiazide	Hydrochlorothiazide	90	40
Montelukast Sodium	Montelukast Sodium	85	28
Temazepam	Temazepam	84	17
Finasteride	Finasteride	81	23
Fluticasone Propionate	Fluticasone Propionate	76	40
Sildenafil Citrate	Sildenafil Citrate	68	22
Metoprolol Succinate	Metoprolol Succinate	66	25
Ibuprofen	Ibuprofen	63	28
Mirtazapine	Mirtazapine	63	21
Sertraline Hcl	Sertraline Hcl	63	21
Clopidogrel	Clopidogrel Bisulfate	62	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	61	14
Pioglitazone Hcl	Pioglitazone Hcl	56	15
Glipizide	Glipizide	55	24
Ciprofloxacin Hcl	Ciprofloxacin Hcl	54	45
Eliquis	Apixaban	51	16
Potassium Chloride	Potassium Chloride	51	22
Alendronate Sodium	Alendronate Sodium	50	22
Trazodone Hcl	Trazodone Hcl	50	21
Zolpidem Tartrate	Zolpidem Tartrate	50	12
Allopurinol	Allopurinol	47	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	13
Amoxicillin	Amoxicillin	46	42
Famotidine	Famotidine	46	24
Fenofibrate	Fenofibrate	46	18
Lorazepam	Lorazepam	46	suppressed
Citalopram Hbr	Citalopram Hydrobromide	45	17
Pravastatin Sodium	Pravastatin Sodium	43	20
Lantus	Insulin Glargine,hum.Rec.Anlog	42	12
Oxybutynin Chloride	Oxybutynin Chloride	40	13
Terazosin Hcl	Terazosin Hcl	40	11
Nifedipine Er	Nifedipine	39	13
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	15
Clonidine Hcl	Clonidine Hcl	37	13
Diazepam	Diazepam	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	13
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Glimepiride	Glimepiride	30	11
Fluoxetine Hcl	Fluoxetine Hcl	29	12
Naproxen	Naproxen	29	19
Novolog	Insulin Aspart	29	suppressed
Verapamil Er	Verapamil Hcl	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	19
Baclofen	Baclofen	26	suppressed
Meloxicam	Meloxicam	26	12
Azithromycin	Azithromycin	25	23
Ondansetron Hcl	Ondansetron Hcl	24	11
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	22	12
Jardiance	Empagliflozin	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Atenolol	Atenolol	19	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Cephalexin	Cephalexin	19	12
Ketoconazole	Ketoconazole	19	11
Bupropion Xl	Bupropion Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Methylprednisolone	Methylprednisolone	16	16
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Ozempic	Semaglutide	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	12
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Testosterone	Testosterone	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	12
Ezetimibe	Ezetimibe	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Linzess	Linaclotide	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Aripiprazole	Aripiprazole	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Topiramate	Topiramate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error